65
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology : Contemporary management of acute RV failure

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Acute right ventricular (RV) failure is a complex clinical syndrome that results from many causes. Research efforts have disproportionately focused on the failing left ventricle, but recently the need has been recognized to achieve a more comprehensive understanding of RV anatomy, physiology, and pathophysiology, and of management approaches. Right ventricular mechanics and function are altered in the setting of either pressure overload or volume overload. Failure may also result from a primary reduction of myocardial contractility owing to ischaemia, cardiomyopathy, or arrhythmia. Dysfunction leads to impaired RV filling and increased right atrial pressures. As dysfunction progresses to overt RV failure, the RV chamber becomes more spherical and tricuspid regurgitation is aggravated, a cascade leading to increasing venous congestion. Ventricular interdependence results in impaired left ventricular filling, a decrease in left ventricular stroke volume, and ultimately low cardiac output and cardiogenic shock. Identification and treatment of the underlying cause of RV failure, such as acute pulmonary embolism, acute respiratory distress syndrome, acute decompensation of chronic pulmonary hypertension, RV infarction, or arrhythmia, is the primary management strategy. Judicious fluid management, use of inotropes and vasopressors, assist devices, and a strategy focusing on RV protection for mechanical ventilation if required all play a role in the clinical care of these patients. Future research should aim to address the remaining areas of uncertainty which result from the complexity of RV haemodynamics and lack of conclusive evidence regarding RV-specific treatment approaches.

          Related collections

          Most cited references97

          • Record: found
          • Abstract: not found
          • Article: not found

          ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Importance of venous congestion for worsening of renal function in advanced decompensated heart failure.

              To determine whether venous congestion, rather than impairment of cardiac output, is primarily associated with the development of worsening renal function (WRF) in patients with advanced decompensated heart failure (ADHF). Reduced cardiac output is traditionally believed to be the main determinant of WRF in patients with ADHF. A total of 145 consecutive patients admitted with ADHF treated with intensive medical therapy guided by pulmonary artery catheter were studied. We defined WRF as an increase of serum creatinine >/=0.3 mg/dl during hospitalization. In the study cohort (age 57 +/- 14 years, cardiac index 1.9 +/- 0.6 l/min/m(2), left ventricular ejection fraction 20 +/- 8%, serum creatinine 1.7 +/- 0.9 mg/dl), 58 patients (40%) developed WRF. Patients who developed WRF had a greater central venous pressure (CVP) on admission (18 +/- 7 mm Hg vs. 12 +/- 6 mm Hg, p < 0.001) and after intensive medical therapy (11 +/- 8 mm Hg vs. 8 +/- 5 mm Hg, p = 0.04). The development of WRF occurred less frequently in patients who achieved a CVP <8 mm Hg (p = 0.01). Furthermore, the ability of CVP to stratify risk for development of WRF was apparent across the spectrum of systemic blood pressure, pulmonary capillary wedge pressure, cardiac index, and estimated glomerular filtration rates. Venous congestion is the most important hemodynamic factor driving WRF in decompensated patients with advanced heart failure.
                Bookmark

                Author and article information

                Journal
                European Journal of Heart Failure
                Eur J Heart Fail
                Wiley
                13889842
                March 2016
                March 2016
                March 15 2016
                : 18
                : 3
                : 226-241
                Affiliations
                [1 ]Emergency Medicine, Helsinki University; Department of Emergency Medicine and Services, Helsinki University Hospital; Helsinki Finland
                [2 ]University Paris Diderot; Sorbonne Paris Cité Paris France
                [3 ]U942 Inserm; AP-HP Paris France
                [4 ]APHP, Department of Anaesthesia and Critical Care; Hôpitaux Universitaires Saint Louis-Lariboisière; Paris France
                [5 ]Clinic of Cardiac and Vascular Diseases, Faculty of Medicine; Vilnius University; Vilnius Lithuania
                [6 ]Institute of Anaesthesiology; University Hospital Zurich; Switzerland
                [7 ]Centro Nacional de Investigaciones Cardiovasculares (CNIC)
                [8 ]Instituto de Investigación i + 12 and Cardiology Department; Hospital Universitario 12 de Octubre, Madrid, Spain
                [9 ]Universidad Complutense de Madrid; Spain
                [10 ]University of Medicine Carol Davila/Institute of Emergency for Cardiovascular Disease; Bucharest Romania
                [11 ]Unidad de Insuficiencia Cardiaca Avanzada y Trasplante Cardiaco; Complexo Hospitalario Universitario A Coruna, CHUAC; La Coruna Spain
                [12 ]Department of Cardiothoracic and Vascular Surgery; Deutsches Herzzentrum Berlin; Berlin Germany
                [13 ]Athens University Hospital Attikon; Athens Greece
                [14 ]Imperial College; London United Kingdom
                [15 ]Departamento de Fisiologia e Cirurgia Cardiotorácica; Faculdade de Medicina, Universidade do Porto; Porto Portugal
                [16 ]Cardiology, Helsinki University; Helsinki University Hospital; Helsinki Finland
                [17 ]Hospital Sant Joan Despí Moisès Broggi and Hospital General de l'Hospitalet; University of Barcelona; Barcelona Spain
                [18 ]Department of Cardiology and Cardiovascular Research Institute Basel (CRIB); University Hospital Basel; Basel Switzerland
                [19 ]Department of Cardiology, Ziekenhuis Oost Limburg, Genk - Biomedical Research Institute, Faculty of Medicine and Life Sciences; Hasselt University; Diepenbeek Belgium
                [20 ]Department of Physiology, Faculty of Medicine; Free University of Brussels; Brussels Belgium
                [21 ]Vrije Universiteit Medisch Centrum; Amsterdam the Netherlands
                [22 ]Attikon University Hospital; Athens Greece
                [23 ]Department of Cardiology of the Clinical Centre of Serbia and; Belgrade University School of Medicine; Belgrade Serbia
                [24 ]IRCCS San Raffaele Hospital Roma; Rome Italy
                [25 ]Cardiovascular and Cell Sciences Institute; St George's University of London; London UK
                [26 ]Cardio-surgical Intensive Care Unit; University Hospital Zurich; Zurich Switzerland
                [27 ]Department of Cardiology, Heart Failure Clinic and Transplantation; University Heart Centre Zurich; Zurich Switzerland
                [28 ]Department of Internal Medicine, Belgrade University School of Medicine and Heart Failure Centre; Belgrade University Medical Centre; Belgrade Serbia
                [29 ]Réanimation polyvalente, Hôpital Antoine Béclère; Hôpitaux univeristaires Paris Sud; AP-HP Clamart France
                [30 ]INSERM U-1018, CESP, Team 5 (EpReC, Renal and Cardiovascular Epidemiology), UVSQ, Villejuif, France; University Hospital Ambroise Paré; Assistance Publique-Hôpitaux de Paris Boulogne-Billancourt France
                [31 ]Department of Cardiology; Cumhuriyet University Faculty of Medicine; Sivas Turkey
                [32 ]Centre for Thrombosis and Haemostasis (CTH); University Medical Centre Mainz; Mainz Germany
                [33 ]Department of Cardiology; Democritus University of Thrace; Alexandroupolis Greece
                Article
                10.1002/ejhf.478
                26995592
                c8976060-8de7-4625-a665-9c0c94f7ac83
                © 2016

                http://doi.wiley.com/10.1002/tdm_license_1.1

                History

                Comments

                Comment on this article

                scite_

                Similar content464

                Cited by172

                Most referenced authors2,256